Manufacturing
live biotherapeutic products is both technically challenging and financially
demanding; as a result, innovator firms are becoming increasingly reliant on
contract service providers to access specialized facilities and optimize
overall costs.
To order this 300+ page report, which features 140+ figures
and 125+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/microbiome-contract-manufacturing/306.html
The USD 300 million (by 2030) financial opportunity
within the microbiome contract manufacturing market has been analysed across
the following segments:
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
The Live
Biotherapeutic Products and Microbiome Contract Manufacturing Market, report features the
following companies, which we identified to be key players in this domain:
§
§
§
§
§
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape
5. Company Profiles
6. Regional Capability Analysis
7. Likely Partner Analysis
8. Clinical Trial Analysis
9. Capacity Analysis
10. Demand Analysis
11. Make versus Buy Decision Making Framework
12. Microbiome related initiatives of Big
Pharmaceutical Players
13. Market Forecast
14. Conclusion
15. Executive Insights
16. Appendix 1: Tabulated Data
17. Appendix 2: List of Companies and Organizations
18. Appendix 3: List of Probiotic Supplement Contract
Manufacturers and
Microbial Contract Service Providers
To
purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/microbiome-contract-manufacturing/306.html
Contact Details
Gaurav
Chaudhary
+1
(415) 800 3415
gaurav.chaudhary@rootsanalysis.com
